Rockwell Selling And Marketing Expenses from 2010 to 2025

RMTI Stock  USD 1.14  0.06  5.00%   
Rockwell Medical's Selling And Marketing Expenses is decreasing with slightly volatile movements from year to year. Selling And Marketing Expenses is estimated to finish at about 3.9 M this year. For the period between 2010 and 2025, Rockwell Medical, Selling And Marketing Expenses quarterly trend regression had mean deviation of  2,411,719 and range of 7 M. View All Fundamentals
 
Selling And Marketing Expenses  
First Reported
2019-03-31
Previous Quarter
726 K
Current Value
843 K
Quarterly Volatility
765.6 K
 
Covid
Check Rockwell Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Rockwell Medical's main balance sheet or income statement drivers, such as Depreciation And Amortization of 2.3 M, Interest Expense of 1.2 M or Total Revenue of 106.6 M, as well as many indicators such as Price To Sales Ratio of 0.59, Dividend Yield of 0.0 or PTB Ratio of 1.85. Rockwell financial statements analysis is a perfect complement when working with Rockwell Medical Valuation or Volatility modules.
  
Check out the analysis of Rockwell Medical Correlation against competitors.
For more detail on how to invest in Rockwell Stock please use our How to Invest in Rockwell Medical guide.

Latest Rockwell Medical's Selling And Marketing Expenses Growth Pattern

Below is the plot of the Selling And Marketing Expenses of Rockwell Medical over the last few years. It is Rockwell Medical's Selling And Marketing Expenses historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Rockwell Medical's overall financial position and show how it may be relating to other accounts over time.
Selling And Marketing Expenses10 Years Trend
Slightly volatile
   Selling And Marketing Expenses   
       Timeline  

Rockwell Selling And Marketing Expenses Regression Statistics

Arithmetic Mean7,188,871
Geometric Mean6,405,619
Coefficient Of Variation39.19
Mean Deviation2,411,719
Median9,050,033
Standard Deviation2,816,971
Sample Variance7.9T
Range7M
R-Value(0.81)
Mean Square Error2.9T
R-Squared0.66
Significance0.0001
Slope(479,873)
Total Sum of Squares119T

Rockwell Selling And Marketing Expenses History

20253.9 M
20242.7 M
20232.1 M
20222.1 M
20215.7 M
20207.9 M

About Rockwell Medical Financial Statements

Investors use fundamental indicators, such as Rockwell Medical's Selling And Marketing Expenses, to determine how well the company is positioned to perform in the future. Although Rockwell Medical's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Selling And Marketing Expenses2.7 M3.9 M

Currently Active Assets on Macroaxis

When determining whether Rockwell Medical offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Rockwell Medical's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Rockwell Medical Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Rockwell Medical Stock:
Check out the analysis of Rockwell Medical Correlation against competitors.
For more detail on how to invest in Rockwell Stock please use our How to Invest in Rockwell Medical guide.
You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Rockwell Medical. If investors know Rockwell will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Rockwell Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.03)
Revenue Per Share
3.268
Quarterly Revenue Growth
0.116
Return On Assets
0.0068
Return On Equity
(0.02)
The market value of Rockwell Medical is measured differently than its book value, which is the value of Rockwell that is recorded on the company's balance sheet. Investors also form their own opinion of Rockwell Medical's value that differs from its market value or its book value, called intrinsic value, which is Rockwell Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Rockwell Medical's market value can be influenced by many factors that don't directly affect Rockwell Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Rockwell Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Rockwell Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Rockwell Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.